Skip to main content
logo
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
23.00
-0.66 (-2.79%)
Sep 9, 2026, 3:14 PM EDT - Market open

Attovia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
32.8340.1930.63
Short-Term Investments
82.3112.0838.69
Cash & Short-Term Investments
115.13152.2769.32
Cash Growth
-119.65%-
Other Receivables
0.90.90.1
Receivables
0.90.90.1
Prepaid Expenses
2.373.133.06
Total Current Assets
118.4156.372.48
Property, Plant & Equipment
6.927.873.23
Other Long-Term Assets
3.031.731
Total Assets
128.35165.8976.72

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
63.554.14
Accrued Expenses
4.585.093.58
Current Portion of Leases
2.041.92-
Current Unearned Revenue
-0.45-
Total Current Liabilities
12.6211.017.72
Long-Term Leases
2.293.34-
Other Long-Term Liabilities
0.680.766.87
Total Liabilities
15.5815.114.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
4.973.473.49
Retained Earnings
-150.35-111.01-50.38
Comprehensive Income & Other
-0.080.10.07
Total Common Equity
-145.46-107.44-46.83
Shareholders' Equity
112.77150.7962.13
Total Liabilities & Equity
128.35165.8976.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
4.335.26-
Net Cash (Debt)
110.81147.0169.32
Net Cash Growth
-112.06%-
Net Cash Per Share
26.8837.2219.63
Filing Date Shares Outstanding
45.654.434.43
Total Common Shares Outstanding
4.534.434.43
Working Capital
105.79145.2964.76
Book Value Per Share
-32.12-24.27-10.58
Tangible Book Value
-145.46-107.44-46.83
Tangible Book Value Per Share
-32.12-24.27-10.58
Machinery
4.734.431.96
Construction In Progress
0.060.031.57
Leasehold Improvements
0.140.14-
SEC Filings: 10-K · 10-Q